FDA Calendar for AEterna Zentaris Inc. (AEZS)

| Register (free)
AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology. The Company’s product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products. The products of the Company include Cetrorelix, AEZS-108, Perifosine, Ozarelix, AEZS-112 and AEZS-130. On March 31, 2008, the Company completed the selling of the Company’s product Impavido to Paladin Labs Inc. (Paladin). On March 5, 2009, the Company entered into a development, commercialization and license agreement with sanofi-aventis for the development, registration and marketing of cetrorelix in benign prostatic hyperplasia (BPH) for the United States market.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
Perifosine KRX-0401 Cancer Fast TrackPhase 3


Events

No future events listed at this time, please check back later.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

AEZS

$1.83
0.03 +1.67%
2/3/2012 3:59:00 PM

Sponsors

Other Links